The Leibniz University Hannover, long form in German Gottfried Wilhelm Leibniz Universität Hannover, is a public research university located in Hanover, Germany. Founded on 2 May 1831, it is one of the largest and oldest science and technology universities in Germany.

During the past decade, University of Hannover conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Hannover" #1 sponsor was "Gottfried Wilhelm Leibniz Universität Hannover" with 2 trials, followed by "Heidelberg University" with 1 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored, "Klaus Herfarth, MD" with 1 trials sponsored and "Martin Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Hannover" #1 collaborator was "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator, "Dutch Cancer Society" with 1 trials as a collaborator and "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "University of Hannover" are "Acute-On-Chronic Liver Failure" (1 trials), "Anaplastic Astrocytoma" (1 trials), "Cholangiocarcinoma" (1 trials), "Gall Bladder Carcinoma" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "University of Hannover" in a lesser frequency.

Most popular intervention types in "University of Hannover" are "Drug" (6 trials), "Dietary Supplement" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Albuferon" (1 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials), "EE" (1 trials) and "Fish oil" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Hannover" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Hannover". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Hannover, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Hannover, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".